Research ArticleArticle
Influence of Environmental Factors on Disease Activity in Spondyloarthritis: A Prospective Cohort Study
Nadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, Maria Antonietta D'Agostino, Jean François Vibert, Clément Turbelin, Homa Madrakian, Emmanuelle Durand, Odile Launay, Alfred Mahr, Antoine Flahault, Maxime Breban and Thomas Hanslik
The Journal of Rheumatology February 2013, jrheum.121081; DOI: https://doi.org/10.3899/jrheum.121081
Nadine Zeboulon-Ktorza
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Pierre Yves Boelle
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Roula Said Nahal
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Maria Antonietta D'Agostino
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Jean François Vibert
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Clément Turbelin
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Homa Madrakian
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Emmanuelle Durand
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Odile Launay
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Alfred Mahr
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Antoine Flahault
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Maxime Breban
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Thomas Hanslik
From the Ambroise Paré Hospital, APHP, Boulogne Billancourt; Versailles Saint-Quentin-en-Yvelines University, Versailles; Inserm UMR-S 707, Paris; UPMC Paris VI University, Paris; Saint Antoine Hospital, APHP, Paris; Cochin Hospital, APHP, Paris; Descartes University, Paris; EHESP School of Public Health, Rennes; and Inserm U 1016, Paris, France. Supported by the National Hospital Clinical Research Program (PHRC, AOM02020) and UCB Pharma. Dr. Zeboulon was supported by a grant from the French Society of Rheumatology. N. Zeboulon-Ktorza, MD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707; P.Y. Boelle, PhD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; R. Said-Nahal, MD, Ambroise Paré Hospital, APHP; M.A. D’Agostino, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University; J.F. Vibert, MD, Inserm UMR-S 707, UPMC Paris VI University, and Saint Antoine Hospital, APHP; C. Turbelin, MD, Inserm UMR-S 707 and UPMC Paris VI University; H. Madrakian, BSc; E. Durand, BSc, Ambroise Paré Hospital, APHP; O. Launay, MD, PhD, Cochin Hospital, APHP, and Descartes University; A. Mahr, MD, PhD, Cochin Hospital, APHP; A. Flahault, MD, PhD, EHESP School of Public Health; M. Breban, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, Descartes University, and Inserm U 1016; T. Hanslik, MD, PhD, Ambroise Paré Hospital, APHP, Versailles Saint-Quentin-en-Yvelines University, and Inserm UMR-S 707. Dr. Breban and Dr. Hanslik contributed equally to this report. Address correspondence to Dr. T. Hanslik, Service de Médecine Interne, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100 Boulogne Billancourt, France. E-mail: thomas.hanslik@apr.aphp.fr Accepted for publication December 7, 2012.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Influence of Environmental Factors on Disease Activity in Spondyloarthritis: A Prospective Cohort Study
Nadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, Maria Antonietta D'Agostino, Jean François Vibert, Clément Turbelin, Homa Madrakian, Emmanuelle Durand, Odile Launay, Alfred Mahr, Antoine Flahault, Maxime Breban, Thomas Hanslik
The Journal of Rheumatology Feb 2013, jrheum.121081; DOI: 10.3899/jrheum.121081
Influence of Environmental Factors on Disease Activity in Spondyloarthritis: A Prospective Cohort Study
Nadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, Maria Antonietta D'Agostino, Jean François Vibert, Clément Turbelin, Homa Madrakian, Emmanuelle Durand, Odile Launay, Alfred Mahr, Antoine Flahault, Maxime Breban, Thomas Hanslik
The Journal of Rheumatology Feb 2013, jrheum.121081; DOI: 10.3899/jrheum.121081